FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593007604> ?p ?o ?g. }

• W2593007604 abstract "The Human Epidermal Growth Factor Receptor 2 (HER2) oncogene is amplified in one-fifth of breast cancers (BC). However, development of resistance against standard anti-HER2 therapies poses a major clinical challenge. Anti-tumor efficacy of HER2-targeting agents depends on inhibition of the downstream phosphatidylinositol-3 kinase (PI3K) signaling cascade. Gain-of-function somatic mutations in the gene encoding the PI3K catalytic subunit p110alpha (PIK3CA), co-expressed in about 40% of HER2+ BC, have been implicated in conferring resistance to HER2 monoclonal antibody herceptin. The single amino acid alteration H1047R within the kinase domain of PIK3CA is one of three hot spot mutations prevalent in BC. Previously, we demonstrated that introduction of H1047R mutation in HER2-overexpressing MCF10A mammary epithelial cells enhances cellular transformation and decreases herceptin sensitivity by inducing secretion of endogenous ErbB ligand heregulin. However, genetic ablation of HER3, the major co-receptor for HER2 and the solitary receptor for heregulin, was insufficient for complete inhibition of cell growth, indicating the existence of additional mechanism/s responsible for the heightened aggressiveness and decreased drug sensitivity of HER2/H1047RPI3K cells. In the current study, we looked further into the molecular changes within these cells that might be responsible for these phenomena. When compared with the HER2/WTPI3K cells, the HER2/H1047RPI3K cells revealed a significant increase in CD44high/CD24low/negative populations, common markers of BC stem cells, as well as molecular and phenotypic changes associated with epithelial-to-mesenchymal transition. These observations are in agreement with previously published report on mouse model of HER2/H1047RPI3K BC. Further analyses demonstrated additional stem cell-associated characteristics in HER2/H1047RPI3K cells, such as expression of angiogenic and inflammatory cytokines, ability to induce chemotaxis and invasion, activation of TGFb and NFKb signaling pathways. Connectivity map (CMap) analysis of the gene expression signatures from HER2/H1047RPI3K cells revealed a negative association with those from BC cells treated with 17AAG, an inhibitor of the heat shock protein 90 (HSP90). In line with this, HER2/H1047RPI3K-expressing cells are found to be more sensitive to HSP90 inhibition compared to the pan-ErbB inhibitor lapatinib. Cancer stem cells are implicated in drug resistance and tumor recurrence. Enrichment of cell population expressing high levels of stem cell markers and stem cell-related features could be one of major mechanisms by which BC cells co-expressing HER2 and H1047RPI3K adapt to anti-HER2 therapeutic agents. Acute dependence on molecular chaperone HSP90 provides a unique, yet practical opportunity to effectively inhibit tumors harboring both molecular alterations, since HSP90 inhibitors have already shown encouraging clinical activity in herceptin-resistant setting. Citation Format: Surendran S, Bhola N, Arteaga CL, Chakraborty K, Chakrabarty A. Introduction of H1047R oncogenic mutation of PI3K p110alpha subunit in HER2-overexpressing mammary epithelial cells confers a stem-like phenotype and acute sensitivity to HSP90 inhibition [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P1-08-10." @default.
• W2593007604 created "2017-03-16" @default.
• W2593007604 creator A5008062526 @default.
• W2593007604 creator A5012305640 @default.
• W2593007604 creator A5048478210 @default.
• W2593007604 creator A5050359262 @default.
• W2593007604 creator A5087908740 @default.
• W2593007604 date "2017-02-14" @default.
• W2593007604 modified "2023-09-27" @default.
• W2593007604 title "Abstract P1-08-10: Introduction of H1047R oncogenic mutation of PI3K p110alpha subunit in HER2-overexpressing mammary epithelial cells confers a stem-like phenotype and acute sensitivity to HSP90 inhibition" @default.
• W2593007604 doi "https://doi.org/10.1158/1538-7445.sabcs16-p1-08-10" @default.
• W2593007604 hasPublicationYear "2017" @default.
• W2593007604 type Work @default.
• W2593007604 sameAs 2593007604 @default.
• W2593007604 citedByCount "0" @default.
• W2593007604 crossrefType "proceedings-article" @default.
• W2593007604 hasAuthorship W2593007604A5008062526 @default.
• W2593007604 hasAuthorship W2593007604A5012305640 @default.
• W2593007604 hasAuthorship W2593007604A5048478210 @default.
• W2593007604 hasAuthorship W2593007604A5050359262 @default.
• W2593007604 hasAuthorship W2593007604A5087908740 @default.
• W2593007604 hasConcept C153911025 @default.
• W2593007604 hasConcept C184235292 @default.
• W2593007604 hasConcept C2779251935 @default.
• W2593007604 hasConcept C2780610907 @default.
• W2593007604 hasConcept C2781465904 @default.
• W2593007604 hasConcept C502942594 @default.
• W2593007604 hasConcept C62478195 @default.
• W2593007604 hasConcept C86803240 @default.
• W2593007604 hasConcept C95444343 @default.
• W2593007604 hasConceptScore W2593007604C153911025 @default.
• W2593007604 hasConceptScore W2593007604C184235292 @default.
• W2593007604 hasConceptScore W2593007604C2779251935 @default.
• W2593007604 hasConceptScore W2593007604C2780610907 @default.
• W2593007604 hasConceptScore W2593007604C2781465904 @default.
• W2593007604 hasConceptScore W2593007604C502942594 @default.
• W2593007604 hasConceptScore W2593007604C62478195 @default.
• W2593007604 hasConceptScore W2593007604C86803240 @default.
• W2593007604 hasConceptScore W2593007604C95444343 @default.
• W2593007604 hasLocation W25930076041 @default.
• W2593007604 hasOpenAccess W2593007604 @default.
• W2593007604 hasPrimaryLocation W25930076041 @default.
• W2593007604 hasRelatedWork W10114956 @default.
• W2593007604 hasRelatedWork W12283502 @default.
• W2593007604 hasRelatedWork W16278512 @default.
• W2593007604 hasRelatedWork W23429827 @default.
• W2593007604 hasRelatedWork W24801689 @default.
• W2593007604 hasRelatedWork W35717447 @default.
• W2593007604 hasRelatedWork W36591980 @default.
• W2593007604 hasRelatedWork W38066706 @default.
• W2593007604 hasRelatedWork W4071369 @default.
• W2593007604 hasRelatedWork W5826924 @default.
• W2593007604 isParatext "false" @default.
• W2593007604 isRetracted "false" @default.
• W2593007604 magId "2593007604" @default.
• W2593007604 workType "article" @default.